All Stories

Shore Cap on Amryt at 18.5p - target price increased from 35p to 88p!

Tom Winnifrith
Sunday 26 March 2017

Shore cap is House broker to Amryt Pharma (AMYT) so everything it writes cannot be said to be any way shape or form impartial. And since we own a shed load of the shares we are biased as hell too. Having said that this note is detailed and lifting the target price from 35p to 88p in light of recent news is pretty dramatic given that the shares were 18.5p on Friday when this "most excellent" research note came out.

on ShareProphets | Comments
About Tom Winnifrith
Bio
Tom Winnifrith is the editor of TomWinnifrith.com. When he is not harvesting olives in Greece, he is (planning to) raise goats in Wales.
Twitter
@TomWinnifrith
Email
[email protected]
Recently Featured on ShareProphets
Sign up for my weekly newsletter








Required Reading

Recent Comments


I also read